Supernus Pharmaceuticals, Inc. (SUPN)
44.22
+0.48
(+1.11%)
USD |
NASDAQ |
Aug 31, 16:00
44.22
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Cash from Operations (Annual) : 47.33M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 47.33M |
| December 31, 2024 | 171.95M |
| December 31, 2023 | 111.08M |
| December 31, 2022 | 116.83M |
| December 31, 2021 | 127.13M |
| December 31, 2020 | 138.40M |
| December 31, 2019 | 143.13M |
| December 31, 2018 | 128.99M |
| December 31, 2017 | 114.64M |
| December 31, 2016 | 66.81M |
| Date | Value |
|---|---|
| December 31, 2015 | 34.52M |
| December 31, 2014 | 7.733M |
| December 31, 2013 | -57.95M |
| December 31, 2012 | -47.20M |
| December 31, 2011 | -36.18M |
| December 31, 2010 | -32.54M |
| December 31, 2009 | 2.634M |
| December 31, 2008 | -29.65M |
| December 31, 2007 | 2.634M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Indivior Pharmaceuticals, Inc. | -27.00M |
| Pfizer Inc. | 11.70B |
| Amphastar Pharmaceuticals, Inc. | 156.12M |
| Collegium Pharmaceutical, Inc. | 329.32M |
| Bristol Myers Squibb Co. | 14.16B |